- By FYH News Team
[ad_1]
doi: 10.1002/dmrr.3744.
Online ahead of print.
1
, Kylie K Harrall
2
3
, Deborah H Glueck
2
3
, Mustafa Tosur
1
4
, Serife Uysal
1
, Andrew Muir
5
, Elizabeth G Atkinson
6
, Melanie R Shapiro
7
, Liping Yu
8
, William E Winter
9
, Michael Weedon
10
, Todd M Brusko
7
11
, Richard Oram
10
, Kendra Vehik
12
, William Hagopian
13
, Mark A Atkinson
7
11
, Dana Dabelea
2
3
; DISCOVER Study Group
Affiliations
Affiliations
- 1 Diabetes and Endocrinology Division, Department of Pediatrics, Texas Children’s Hospital, Baylor College of Medicine, Houston, Texas, USA.
- 2 Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- 3 Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
- 4 Children’s Nutrition Research Center, USDA/ARS, Houston, Texas, USA.
- 5 Department of Pediatrics, Emory University, Atlanta, Georgia, USA.
- 6 Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
- 7 Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, Diabetes Institute, University of Florida, Gainesville, Florida, USA.
- 8 Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, Colorado, USA.
- 9 Departments of Pathology and Pediatrics, University of Florida, Gainesville, Florida, USA.
- 10 Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.
- 11 Department of Pediatrics, College of Medicine, Diabetes Institute, University of Florida, Gainesville, Florida, USA.
- 12 Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
- 13 Pacific Northwest Research Institute, Seattle, Washington, USA.
Item in Clipboard
Maria J Redondo et al.
Diabetes Metab Res Rev.
.
Display options
Format
doi: 10.1002/dmrr.3744.
Online ahead of print.
Authors
1
, Kylie K Harrall
2
3
, Deborah H Glueck
2
3
, Mustafa Tosur
1
4
, Serife Uysal
1
, Andrew Muir
5
, Elizabeth G Atkinson
6
, Melanie R Shapiro
7
, Liping Yu
8
, William E Winter
9
, Michael Weedon
10
, Todd M Brusko
7
11
, Richard Oram
10
, Kendra Vehik
12
, William Hagopian
13
, Mark A Atkinson
7
11
, Dana Dabelea
2
3
; DISCOVER Study Group
Affiliations
- 1 Diabetes and Endocrinology Division, Department of Pediatrics, Texas Children’s Hospital, Baylor College of Medicine, Houston, Texas, USA.
- 2 Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- 3 Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
- 4 Children’s Nutrition Research Center, USDA/ARS, Houston, Texas, USA.
- 5 Department of Pediatrics, Emory University, Atlanta, Georgia, USA.
- 6 Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
- 7 Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, Diabetes Institute, University of Florida, Gainesville, Florida, USA.
- 8 Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, Colorado, USA.
- 9 Departments of Pathology and Pediatrics, University of Florida, Gainesville, Florida, USA.
- 10 Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.
- 11 Department of Pediatrics, College of Medicine, Diabetes Institute, University of Florida, Gainesville, Florida, USA.
- 12 Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
- 13 Pacific Northwest Research Institute, Seattle, Washington, USA.
Item in Clipboard
Display options
Format
Abstract
Aims:
Determining diabetes type in children has become increasingly difficult due to an overlap in typical characteristics between type 1 diabetes (T1D) and type 2 diabetes (T2D). The Diabetes Study in Children of Diverse Ethnicity and Race (DISCOVER) programme is a National Institutes of Health (NIH)-supported multicenter, prospective, observational study that enrols children and adolescents with non-secondary diabetes. The primary aim of the study was to develop improved models to differentiate between T1D and T2D in diverse youth.
Materials and methods:
The proposed models will evaluate the utility of three existing T1D genetic risk scores in combination with data on islet autoantibodies and other parameters typically available at the time of diabetes onset. Low non-fasting serum C-peptide (<0.6 nmol/L) between 3 and 10 years after diabetes diagnosis will be considered a biomarker for T1D as it reflects the loss of insulin secretion ability. Participating centres are enrolling youth (<19 years old) either with established diabetes (duration 3-10 years) for a cross-sectional evaluation or with recent onset diabetes (duration 3 weeks-15 months) for the longitudinal observation with annual visits for 3 years. Cross-sectional data will be used to develop models. Longitudinal data will be used to externally validate the best-fitting model.
Results:
The results are expected to improve the ability to classify diabetes type in a large and growing subset of children who have an unclear form of diabetes at diagnosis.
Conclusions:
Accurate and timely classification of diabetes type will help establish the correct clinical management early in the course of the disease.
Keywords:
C-peptide; atypical diabetes; classification; diabetes genetic risk score; diagnosis; paediatric diabetes; type 1 diabetes; type 2 diabetes.
© 2023 John Wiley & Sons Ltd.
References
REFERENCES
-
-
Committee ADAPP. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17-S38. https://doi.org/10.2337/dc22-s002
-
-
-
Hannon TS, Arslanian SA. The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes. Ann N Y Acad Sci. 2015;1353(1):113-137. https://doi.org/10.1111/nyas.12939
-
-
-
Redondo MJ, Rodriguez LM, Escalante M, Smith EO, Balasubramanyam A, Haymond MW. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis. Pediatr Diabetes. 2013;14(5):333-340. https://doi.org/10.1111/pedi.12022
-
-
-
Zeitler P, Fu J, Tandon N, et al. ISPAD clinical practice consensus guidelines 2014. Type 2 diabetes in the child and adolescent. Pediatr Diabetes. 2014;15((Suppl 20)):26-46. https://doi.org/10.1111/pedi.12179
-
-
-
Ogden CL, Carroll MD, Lawman HG, et al. Trends in obesity prevalence among children and adolescents in the United States, 1988-1994 through 2013-2014. JAMA. 2016;315(21):2292-2299. https://doi.org/10.1001/jama.2016.6361
-
Cite
[ad_2]
Source link
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
- Subash Kafle
- Victor Mejia
- Victor Mejia


















